Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.475
Bid: 1.45
Ask: 1.50
Change: 0.025 (1.72%)
Spread: 0.05 (3.448%)
Open: 1.475
High: 1.50
Low: 1.45
Prev. Close: 1.45
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

Wed, 03rd Apr 2024 16:54

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

The FTSE 100 index closed up 2.35 points at 7,937.44. The FTSE 250 ended up 39.75 points, 0.2%, at 19,753.64, and the AIM All-Share closed down 0.32 of a point at 742.08.

The Cboe UK 100 ended down 0.1% at 793.01, the Cboe UK 250 closed up 0.1% at 17,166.93, and the Cboe Small Companies ended up 0.7% at 14,656.34.

In European equities on Wednesday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt ended up 0.5%.

On Wednesday afternoon, there has been some US data for investors to digest.

The US private sector added more jobs in March than a month earlier, numbers from payroll processor ADP showed on Wednesday.

Private sector employment increased by 184,000 jobs in March, rising from 155,000 in February.

February's job growth was ahead of the FXStreet-cited market consensus of 148,000.

Annual wage growth for job-changers rose by 5.1% in March. For job stayers annual wage growth increased by 10%.

"The market is increasingly assuming that a US rate cut is some months away," said Kathleen Brooks, research director at XTB.

"After another strong data report, this time the March ADP private sector payrolls report, the market is increasingly expecting fewer rate cuts from the Fed this year, with the first rate cut currently on a knife edge between July and September."

Meanwhile, a senior bank official said the current strength of the US economy means the Federal Reserve should cut interest rates just once this year, and not until the final quarter.

Atlanta Fed President Raphael Bostic, who is a voting member of the Fed's rate-setting committee this year, told CNBC he now thinks the Fed should make just one cut this year – below the three that were predicted by Fed officials in March.

There was also data on the US service sector.

The seasonally adjusted S&P Global US Services purchasing managers' index edged down to 51.7 in March, a three-month low, from 52.3 in February. Falling closer to the 50-mark separating growth from contraction, it indicates growth decelerated.

Meanwhile, the S&P Global US composite PMI output index fell to 52.1 in March from 52.5 in February.

Separately, the Institute for Supply Management reported that the services PMI edged down to 51.4 in March from 52.6 in February.

"The renewed fall in the ISM services index in March is consistent with the message from the hard data that economic growth is slowing from the unsustainably strong pace in the second half of last year," analysts at Capital Economics said.

Stocks in New York were higher at the London equities close, with the DJIA up 0.2%, the S&P 500 index up 0.4%, and the Nasdaq Composite up 0.6%.

The pound was quoted at USD1.2630 at the London equities close Wednesday, up compared to USD1.2564 at the close on Tuesday. The euro stood at USD1.0827 at the European equities close Wednesday, higher against USD1.0771 at the same time on Tuesday. Against the yen, the dollar was trading at JPY151.72, up compared to JPY151.60 late Tuesday.

In London's FTSE 100, Prudential lost 2.7% to 720.40 pence, after Barclays cut the insurer's price target to 1,390p per share from 1,640p, while Barclays rates the stock at 'overweight'.

In the FTSE 250, International Distributions Services rose 4.3%.

IDS unit Royal Mail proposed a change to its UK letter delivery offering, as it grapples with weaker volumes, in a move which could see "fewer than 1,000 voluntary redundancies".

The measures could trim the net cost of the UK postal universal service operation by GBP300 million per year.

"This is very dependent on how quickly reform is enacted and the rate of letter decline. These savings would allow Royal Mail to continue to invest in the modernisation and transformation of the business to provide products and services that customers want and reduce its environmental impact," IDS said.

On AIM, Genedrive shares surged 39%.

The molecular diagnostics company announced that the UK's National Institute for Health & Care Excellence has recommended in draft guidance that Genedrive's CYP2C19-ID test should be used as the point-of-care test of choice for ischemic stroke and transient ischaemic attack patients.

Brent oil was quoted at USD89.69 a barrel at the London equities close Wednesday, up from USD88.11 late Tuesday.

Gold was quoted at USD2,286.90 an ounce at the London equities close Wednesday, up against USD2,266.55 at the close on Tuesday.

In Thursday's UK corporate calendar, there are full year results from LungLife AI.

The economic calendar for Thursday has a producer price reading from the eurozone at 1000 BST.

There is also a slew of composite PMI data from the eurozone, Germany, and the UK.

Across the Atlantic, there is the weekly initial jobless claims from the US.

Meanwhile, financial markets will be closed in Hong Kong and Shanghai will be closed for Tomb Sweeping Day.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
24 May 2024 17:05

LONDON MARKET CLOSE: FTSE 100 stumbles as rain dampens retail sales

(Alliance News) - Stock prices in London closed mixed on Friday, with the FTSE 100 finishing lower, but smaller indices ending in the green.

Read more
24 May 2024 15:54

UK shareholder meetings calendar - next 7 days

Monday 27 May 
no events scheduled 
Tuesday 28 May 
Apollon Formularies PLCEGM re withdrawal from Aquis
Diversified Energy Co PLCGM
TMT Investments PLCAGM
Wednesday 29 May 
B&M European Value Retail SAAGM
Biome Technologies PLCAGM
Frenkel Topping Group PLCAGM
Glencore PLCAGM
Ilika PLCGM re equity raise
Integrated Diagnostic Holdings PLCAGM
Smarttech247 Group PLCAGM
Watchstone Group PLCAGM
Xaar PLCAGM
Thursday 30 May 
Aferian PLCAGM
Ashtead Technology Holdings PLCAGM
Bodycote PLCAGM
Endeavour Mining PLCAGM
Ferguson PLCEGM re merger agreement
Kelso Group Holdings PLCAGM
Learning Technologies Group PLCAGM
LifeSafe Holdings PLCGM re retail offer
Mast Energy Developments PLCAGM
National World PLCAGM
One Media iP Group PLCAGM
RM Infrastructure Income PLCAGM
Friday 31 May 
AG Barr PLCAGM
Alba Mineral Resources PLCAGM
Bushveld Minerals LtdGM re sale of Vanchem
Frenkel Topping Group PLCAGM
Genedrive PLCGM re share placing and open offer
Old Mutual LtdAGM
Pulsar Group PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 May 2024 12:24

Genedrive test ordered by five Manchester area hospitals

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced on Friday that it has received initial orders for its Genedrive MT-RNR1 products from five additional UK hospitals in the Greater Manchester area.

Read more
24 May 2024 12:00

LONDON MARKET MIDDAY: FTSE 100 in red as UK election heats up

(Alliance News) - Stock prices in London were mostly in the red at midday Friday, as the UK election debate heats up and retail sales come in below expectations.

Read more
24 May 2024 11:31

Genedrive announces orders for testing kit worth over GBP100,000

(Alliance News) - Genedrive PLC on Friday said it had received initial UK orders for its MT-RNR1 testing kit.

Read more
24 May 2024 10:37

AIM WINNERS & LOSERS: Kinovo rises as results ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
21 May 2024 21:50

TRADING UPDATES: CVS sells Dutch and Irish loss-making businesses

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
10 May 2024 12:10

IN BRIEF: Genedrive completes placing portion of GBP6 million raise

Genedrive PLC - Manchester-based pharmacogenetic testing - Completes placing of 138.8 million new shares at 1.5 pence each, raising GBP2.1 million. The placing is part of an overall equity raise being run by Peel Hunt LLP. Late Thursday, Genedrive had said it will try to raise a minimum of GBP6.0 million, including offers to retail investors. If that minimum is not reached, then only the firm placing will go ahead. The placing and retail offer prices will be the same and represent a more than 50% discount to Genedrive's closing price on Thursday. The placing shares will almost double Genedrive's total, and the retail offers could see another 376.4 million new shares issued. It expects to call a general meeting for May 31 to approve the share issue.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
10 May 2024 07:00

IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer

Genedrive PLC - Manchester-based pharmacogenetic testing company - Seeks to raise a minimum of GBP6.0 million from an offer of new shares at 1.5 pence each. The announcement is made after the London market close on Thursday, and the price represents a more than 50% discount to Genedrive's closing price. The equity raise will be split into a firm placing of shares for GBP2.5 million, an offer to new and existing retail investors via the REX platform for GBP3.5 million, and an open offer to existing shareholders for GBP2.1 million. Genedrive says that if the GBP6.0 million minimum target is not reached, then only the firm placing will go ahead. The share sale is being run by broker Peel Hunt LLP.

Read more
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.